These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1257276)

  • 41. Influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part III. Ketamine anesthesia.
    Orszulak-Michalak D
    Pol J Pharmacol; 1995; 47(5):407-16. PubMed ID: 8868132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ajmaline and N-propylajmaline on maximum follow frequency and contractility of the dog heart: short communication.
    Raschack M
    Arzneimittelforschung; 1975 Jun; 25(6):896-8. PubMed ID: 1174325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
    Kurmukov AG; Ermishina OA
    Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic and cardiovascular properties of 17-monochloroacetylajmaline (17-MCAA).
    Capra C; Cristoni A; Lietti A; Picci M; Santi-Soncin E
    Farmaco Prat; 1980 Feb; 35(2):49-70. PubMed ID: 7449939
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sotahexal pharmacodynamics in patients with ischemic heart disease].
    Dorofeeva EIu; Gorshkov VA; Chestukhin VV; Lyskovtsev VV; Bezprozvannyĭ AB; Avdeĭchuk ED; Kesarev GV; Lazutina OM; Nesvetov VN; Radzevich AE
    Ter Arkh; 1997; 69(8):17-9. PubMed ID: 9381384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
    Cosío FG; Delpón E
    Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular and antiarrhythmic effects of carnitine.
    DiPalma JR; Ritchie DM; McMichael RF
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):246-50. PubMed ID: 1190919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.
    Spilker B; Shargel L; Koss RF; Minatoya H
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):63-78. PubMed ID: 1164107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of hemodynamic effects of anti-arrhythmic agents. I. Ajmaline and procaine amide].
    Mibuyamba P; Lisin N; Carlier J
    Acta Cardiol; 1971; 26(4):365-80. PubMed ID: 5316295
    [No Abstract]   [Full Text] [Related]  

  • 56. ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
    Lindner E; Schölkens B
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):19-23. PubMed ID: 4367710
    [No Abstract]   [Full Text] [Related]  

  • 57. [The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)].
    Raff U; Hepp A
    Z Kardiol; 1977 Feb; 66(2):61-5. PubMed ID: 842073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 10-N substituted phenothiazine derivatives in auricular arrhythmias.
    Singh KP; Sharma VN
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):168-78. PubMed ID: 5353874
    [No Abstract]   [Full Text] [Related]  

  • 59. Do class 1 antiarrhythmic drugs impair myocardial contractility? The class 1A example of ajmaline (conductance catheter technique).
    Thormann J; Hüting J; Kremer P; Wissemann J; Bahawar H; Schlepper M
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):182-90. PubMed ID: 1697372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Polygraphic study of the effects on myocardial contractility of a new anti-arrhythmic drug: N-propyl-ajmaline bitartrate].
    De Luca I; Cristallo E; Landriscina B; Gianfrate P; Albanese P; Bacca F
    Boll Soc Ital Cardiol; 1975; 20(4):335-41. PubMed ID: 1231913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.